ANO6 and COVID-19: Notably, SARS-CoV-2 S induces internal Ca2+ rise and TMEM16F activation for PS exposure that facilitates host cell membrane fusion with the viral envelope; inhibitors that reduce TMEM16F lipid scramblase activity exhibit antiviral activities against SARS-CoV-2 infection, while their binding sites remain to be determined22.